Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 58 of 1714:
48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type III, beta GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type XI, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type I, beta GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type 10, alpha polypeptide GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type IV, alpha polypeptide GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type V, alpha polypeptide GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type II, beta GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, nonvoltage-gated 1 alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, nonvoltage-gated 1 gamma GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
calcium channel, voltage-dependent, beta 2 subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, alpha 1F subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, beta 1 subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
5-hydroxytryptamine (serotonin) receptor 2B BOPINDOLOL Serotonin 5-HT2B 80% 1.523uM .969uM View
Cytochrom P450-1A2 monooxygenase RESVERATROL CYP450-1A2 Inhibition 80% 3uM NoneNone View
thromboxane A synthase 1 SAQUINAVIR Thromboxane Synthetase 80% 2.182uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) SAQUINAVIR Thromboxane Synthetase 80% 2.182uM NoneNone View
Cytochrom P450-1A2 monooxygenase SAFROLE CYP450-1A2 Inhibition 80% 10uM NoneNone View
progesterone receptor NANDROLONE Progesterone 80% .1715uM .0224uM View
progesterone receptor NANDROLONE Progesterone 80% .1715uM .0224uM View
Sigma-2 Receptor OXYBUTYNIN Sigma2 80% 1.333uM .8203uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, beta 1 subunit ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, gamma subunit 8 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, gamma subunit 7 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, gamma subunit 6 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, gamma subunit 5 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, gamma subunit 4 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, gamma subunit 3 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, gamma subunit 2 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
calcium channel, voltage-dependent, gamma subunit 1 ORPHENADRINE Calcium Channel Type L, Benzothiazepine 80% 2.232uM 1.984uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) MC 258714 CYP450-2C9 Inhibition 80% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 MC 258714 CYP450-2C9 Inhibition 80% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Serotonin 5-HT2C 80% 1.59uM .833uM View
androgen receptor 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Testosterone 80% 2.16uM 1.44uM View
5-hydroxytryptamine (serotonin) receptor 1A CHLORPROMAZINE Serotonin 5-HT1A 80% 4.685uM 2.677uM View
mu-opioid receptor MOR AMIODARONE Opiate mu 80% 19.037uM 7.728uM View
cholinergic receptor, muscarinic 1 BETAMETHASONE PHOSPHATE Muscarinic M1 80% 6.959uM 1.676uM View
dopamine receptor 2 YOHIMBINE Dopamine D2L 80% 2.06uM .687uM View
Sigma-2 Receptor DICYCLOMINE Sigma2 80% .471uM .29uM View
histamine receptor H 2 CLOMIPRAMINE Histamine H2 80% 2.049uM 2.015uM View
5-hydroxytryptamine (serotonin) receptor 1A TIMOLOL Serotonin 5-HT1A 80% 2.712uM 1.55uM View
Cytochrom P450-1A2 monooxygenase CAPSAICIN CYP450-1A2 Inhibition 80% 3uM NoneNone View
mitogen activated protein kinase 1 MECLOFENAMIC ACID Protein Serine/Threonine Kinase, ERK2 80% 3.144uM NoneNone View
mitogen-activated protein kinase 1 MECLOFENAMIC ACID Protein Serine/Threonine Kinase, ERK2 80% 3.144uM NoneNone View
prostaglandin-endoperoxide synthase 2 MELOXICAM Cyclooxygenase COX-2 80% .938uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) MELOXICAM Cyclooxygenase COX-2 80% .938uM NoneNone View
prostaglandin-endoperoxide synthase 2 MONOBENZONE Cyclooxygenase COX-2 80% 3.726uM NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type XI, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, nonvoltage-gated 1, gamma BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, nonvoltage-gated 1, delta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, nonvoltage-gated 1 alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type X, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type IX, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage gated, type VIII, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type VII, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type IV, beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type IV, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type III, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type II, beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type II, alpha 2 BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type I, beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type I, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
dopamine receptor 2 QUETIAPINE Dopamine D2L 79% 1.3299uM .4433uM View
dopamine receptor D1A DIHYDROERGOCRISTINE MESYLATE Dopamine D1 79% 1.179uM .589uM View
mitogen activated protein kinase 14 NELFINAVIR Protein Serine/Threonine Kinase, p38alpha 79% 18.224uM NoneNone View
mitogen-activated protein kinase 14 NELFINAVIR Protein Serine/Threonine Kinase, p38alpha 79% 18.224uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 NELFINAVIR Dopamine Transporter 79% 15.525uM 12.335uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PENTAMIDINE Dopamine Transporter 79% 3.159uM 2.51uM View
matrix metallopeptidase 9 PRAZOSIN Protease, Matrix Metalloprotease-9 (MMP-9) 79% 6.963uM NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) PRAZOSIN Protease, Matrix Metalloprotease-9 (MMP-9) 79% 6.963uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, gamma subunit 7 FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, gamma subunit 6 FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, gamma subunit 5 FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, gamma subunit 4 FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, gamma subunit 3 FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, gamma subunit 2 FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, gamma subunit 1 FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, beta 4 subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, beta 3 subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, beta 2 subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, alpha 1F subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, beta 1 subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit FENOFIBRATE Calcium Channel Type L, Dihydropyridine 79% 17.672uM 11.361uM View
mitogen activated protein kinase 3 BETA-NAPHTHOFLAVONE Protein Serine/Threonine Kinase, ERK1 79% 5.4667uM NoneNone View
mitogen-activated protein kinase 3 BETA-NAPHTHOFLAVONE Protein Serine/Threonine Kinase, ERK1 79% 5.4667uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
sodium channel, nonvoltage-gated 1 beta GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type XI, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, nonvoltage-gated 1, gamma GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, nonvoltage-gated 1, delta GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, nonvoltage-gated 1 alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type X, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type IX, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage gated, type VIII, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type VII, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type IV, beta GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type IV, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type III, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type II, beta GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
histamine receptor H 1 SULOCTIDIL Histamine H1, Central 82% 5.1768uM 2.4759uM View
epidermal growth factor receptor CHROMIUM(III) CHLORIDE Protein Tyrosine Kinase, EGF Receptor 82% 2.955uM NoneNone View
dopamine receptor D3 DESLORATADINE Dopamine D3 82% 1.906uM .647uM View
dopamine receptor D1A TERFENADINE Dopamine D1 82% 2.673uM 1.337uM View
Cytochrom P450-2D6 monooxygenase RWJ-68354 CYP450-2D6 Inhibition 82% .2uM NoneNone View
Cytochrom P450-2D6 monooxygenase OXICONAZOLE CYP450-2D6 Inhibition 82% 1uM NoneNone View
Cytochrom P450-2D6 monooxygenase TACRINE CYP450-2D6 Inhibition 82% .3uM NoneNone View
Cytochrom P450-2C19 monooxygenase NIFURSOL CYP450-2C19 Inhibition 82% 5uM NoneNone View
Cytochrom P450-2C19 monooxygenase NORTRIPTYLINE CYP450-2C19 Inhibition 82% 3uM NoneNone View
thromboxane A synthase 1 3,3',4',5-TETRACHLOROSALICYLANILIDE Thromboxane Synthetase 82% 4.927uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) 3,3',4',5-TETRACHLOROSALICYLANILIDE Thromboxane Synthetase 82% 4.927uM NoneNone View
adrenergic receptor, alpha 2a ALPHA-ERGOCRYPTINE Imidazoline I2, Central 82% .003279uM .002186uM View
adrenergic receptor, alpha 2c (Non-specific probe) ALPHA-ERGOCRYPTINE Imidazoline I2, Central 82% .003279uM .002186uM View
mu-opioid receptor MOR ALPHA-ERGOCRYPTINE Opiate mu 82% 2.427uM .985uM View
ATPase, Na+/K+ transporting, alpha 4 polypeptide BITHIONOL ATPase, Na+/K+ 82% 5.022uM NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide BITHIONOL ATPase, Na+/K+ 82% 5.022uM NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide BITHIONOL ATPase, Na+/K+ 82% 5.022uM NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide BITHIONOL ATPase, Na+/K+ 82% 5.022uM NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide BITHIONOL ATPase, Na+/K+ 82% 5.022uM NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide BITHIONOL ATPase, Na+/K+ 82% 5.022uM NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide BITHIONOL ATPase, Na+/K+ 82% 5.022uM NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide BITHIONOL ATPase, Na+/K+ 82% 5.022uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, gamma subunit 7 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, gamma subunit 6 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, gamma subunit 5 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, gamma subunit 4 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, gamma subunit 3 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, gamma subunit 2 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, gamma subunit 1 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, beta 4 subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, beta 3 subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, beta 2 subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, alpha 1F subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) MONOBENZONE Cyclooxygenase COX-2 80% 3.726uM NoneNone View
adrenergic receptor, alpha 2b TERFENADINE Adrenergic alpha2C 80% 3.748uM .545uM View
adrenergic receptor, alpha 2c (Non-specific probe) TERFENADINE Adrenergic alpha2C 80% 3.748uM .545uM View
adrenergic receptor, alpha 1a GUANFACINE Adrenergic alpha1A 80% 1.348uM .546uM View
opioid receptor, sigma 1 CITALOPRAM Sigma1 80% .398uM .167uM View
cholinergic receptor, muscarinic 2 MIANSERIN Muscarinic M2 80% 1.078uM .383uM View
sodium channel, voltage-gated, type IV, beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel associated protein 1 MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel associated protein 2 MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type III, beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type I, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type IX, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type VII, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
amiloride-sensitive cation channel 5, intestinal MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type III, beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type XI, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type I, beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type 10, alpha polypeptide MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type IV, alpha polypeptide MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type V, alpha polypeptide MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type II, beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, nonvoltage-gated 1 alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, nonvoltage-gated 1 gamma MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, nonvoltage-gated 1 beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type XI, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, nonvoltage-gated 1, gamma MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, nonvoltage-gated 1, delta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, nonvoltage-gated 1 alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type X, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type IX, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage gated, type VIII, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type VII, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type IV, beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type IV, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type III, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type II, beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View